SBR-759
N/A
Report date: 2022/07/04 19:38:02
NME
Base Information
Drug NameSBR-759
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[16]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesSebo Pharma
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesMipharm SpaNovartis Pharma AgBeijing Novartis Pharma Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A